MedPath

The Inflammatory Response to Stress and Angiogenesis in Liver Resection

Not Applicable
Completed
Conditions
Liver Metastases
Liver Cancer
Colorectal Cancer
Metastatic Cancer
Interventions
Procedure: Liver resection
Registration Number
NCT03131778
Lead Sponsor
University Hospital, Ghent
Brief Summary

Patients with resectable liver metastases of colorectal origin will be assigned to laparoscopic liver resection or conventional open liver surgery.

Blood samples will be drawn preoperatively and 24 hours after resection. Determination of Interleukin-6 (IL-6) and IL-8 will be done to assess the stress response between open and laparoscopic liver resection (Elisa test).

The Messenger Ribonucleic Acid (mRNA) of inflammation related factors (cyclooxygenase-2 (COX-2) and Matrix metalloproteinase (MMP-9)), angiogenesis related factor (vascular endothelial growth factor (VEGF) and hypoxia induced factor-1 (HIF-1)) in tumor tissue and normal liver parenchyma will be detected by real-time real time-Polymerase Chain Reaction (RT-PCR).

Detailed Description

According to the null hypothesis, no difference in the IL6 postoperative value, between the two groups would be expected. To calculate sample size, a IL6 postoperative value of 100±40 pg/mL in the laparoscopic group and 60±40 mL/m pg/mL in the open group was hypothesized. Considering a two-sided α=0.05 and β=0.1, the minimal sample size required to achieve statistical significance was 17 subjects in both groups in a 1:1 randomization. Laparoscopic group was increased by 20% of patients considering a conversion rate of 20% accordingly. Randomization will be performed using computer-generated random numbers the day before operation and stopped when 20 patients per group will be reached.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. 18-80 years old
  2. Patients with colorectal liver metastases
  3. Colorectal liver metastases ≤10 cm in size -
Exclusion Criteria
  1. Patients not fit for laparoscopic surgery due to comorbidities
  2. Patients with tumors close or infiltrating the major vessels -

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Open Liver ResectionLiver resectionConventional open liver resection trough subcostal incision
Laparoscopic Liver ResectionLiver resectionPure laparoscopic liver resection without hand assistance
Primary Outcome Measures
NameTimeMethod
Differences in inflammatory responsePreoperative and postoperative day 1

Differences in POD 1 levels of IL6 and IL8

Secondary Outcome Measures
NameTimeMethod
Overall Survival1-3-5 years

From surgery to date of death or last follow up. Data will be reported in months

Differences in tumor stimulating factorsOne week after surgery

Differences in levels of VEGF, HIF-1α, MMP-9 and COX2 in both humoral and normal liver tissue

Recurrence free survival1-3-5 years

From surgery to recurrence either in the liver or elsewhere. Data will be reported in months

© Copyright 2025. All Rights Reserved by MedPath